Shao, Miner
Yao, Jie
Wang, Yunke
Zhao, Lufeng
Li, Baizhou
Li, Lili
Wu, Zuqun
Chen, Zexin
Fan, Junqiang
Qiu, Fuming http://orcid.org/0000-0001-5793-1023
Funding for this research was provided by:
National Natural Science Foundation of China (81472640, 81672802, 82273268)
Natural Science Foundation of Zhejiang Province (No. LZ17H160004)
the Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
The Key R&D Program of Zhejiang
Article History
Received: 19 October 2022
Revised: 27 January 2023
Accepted: 8 February 2023
First Online: 10 April 2023
Competing interests
: The authors declare no competing interests.
: The neoSCORE trial was approved by the local independent ethics committee and conducted according to Good Clinical Practice and the Declaration of Helsinki. This trial was registered under ID: NCT04459611 (ExternalRef removed). All patients provided written informed consent before enrollment.